|
DE3264450D1
(en)
*
|
1981-12-11 |
1985-08-01 |
Wyeth John & Brother Ltd |
Process and apparatus for freezing a liquid medium
|
|
US4942162A
(en)
|
1982-03-31 |
1990-07-17 |
University Of Tennessee Research Corporation |
Topical treatment of seborrheic dermatitis with ketoconazole
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4594329A
(en)
|
1984-05-14 |
1986-06-10 |
The Salk Institute For Biological Studies |
CRF analogs
|
|
US4605642A
(en)
|
1984-02-23 |
1986-08-12 |
The Salk Institute For Biological Studies |
CRF antagonists
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4661493A
(en)
|
1985-03-29 |
1987-04-28 |
Pfizer Inc. |
Tioconazole and related compounds for control of Herpes simplex virus
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US5016655A
(en)
|
1986-10-21 |
1991-05-21 |
C.A. Blockers, Inc. |
Cigarette manufacturing process
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
US4814333A
(en)
|
1987-07-28 |
1989-03-21 |
The Trustees Of Dartmouth College |
Method for treatment of hypercortisolemic, depressed patients
|
|
US4925844A
(en)
|
1988-02-09 |
1990-05-15 |
Ici Americas Inc. |
Antagonizing the pharmacological effects of a benzodiazepine receptor agonist
|
|
US5006528A
(en)
|
1988-10-31 |
1991-04-09 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
|
DE3842007A1
(de)
|
1988-12-14 |
1990-06-21 |
Henkel Kgaa |
Fluessiges bis pastoeses, bleichmittelhaltiges waschmittel
|
|
US4974729A
(en)
|
1989-04-17 |
1990-12-04 |
Bristol-Myers Squibb Company |
Reminder system for taking medication
|
|
WO1991000906A1
(en)
|
1989-07-12 |
1991-01-24 |
Genetics Institute, Inc. |
Chimeric and transgenic animals capable of producing human antibodies
|
|
US5008528A
(en)
|
1989-07-14 |
1991-04-16 |
Logitech S.A. |
Invertible trackball
|
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
|
JPH06506105A
(ja)
|
1990-08-29 |
1994-07-14 |
ファーミング ビーブイ |
哺乳動物細胞における相同性組換え
|
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
US6323312B1
(en)
|
1994-12-12 |
2001-11-27 |
The Salk Institute For Biological Studies |
Cyclic CRF antagonist peptides
|
|
US6326463B1
(en)
|
1994-12-12 |
2001-12-04 |
The Salk Institute For Biological Studies |
Cyclic CRF agonists
|
|
US20030211157A1
(en)
|
1996-05-06 |
2003-11-13 |
Simon David Lew |
Semi-sol delivery blend for water soluble molecules
|
|
US5869474A
(en)
|
1997-05-16 |
1999-02-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Low dosage treatment for cocaine craving and withdrawal
|
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
|
NZ334627A
(en)
|
1999-03-12 |
2002-07-26 |
Horticulture & Food Res Inst |
A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
|
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
|
GB0001449D0
(en)
|
2000-01-21 |
2000-03-08 |
Cortendo Ab |
Compositions
|
|
US6630449B2
(en)
|
2000-12-21 |
2003-10-07 |
David Wastchak |
Method for reducing the effect of nicotine addiction and dependancy
|
|
AU2002322475B2
(en)
|
2001-06-26 |
2008-02-21 |
North Carolina State University |
Blocking peptide for inflammatory cell secretion
|
|
GB0205253D0
(en)
|
2002-03-06 |
2002-04-17 |
Univ Gent |
Immediate release pharmaceutical granule compositions and a continuous process for making them
|
|
EP2011489A3
(en)
|
2002-07-09 |
2009-04-22 |
Roberta Gottlieb |
Method to inhibit ischemia and reperfusion injury
|
|
KR100503889B1
(ko)
|
2002-07-20 |
2005-07-26 |
한국과학기술연구원 |
옥틸로늄 브로마이드를 함유하는 항암제 흡수 증진제
|
|
MXPA05000294A
(es)
|
2002-07-30 |
2005-08-19 |
Peter Migaly |
Terapia combinada para la depresion, prevencion de suicidios y varias condiciones medicas y psiquiatricas.
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
US20040067986A1
(en)
|
2002-10-04 |
2004-04-08 |
Nathan Sassover |
Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer
|
|
US20050037983A1
(en)
|
2003-03-11 |
2005-02-17 |
Timothy Dinan |
Compositions and methods for the treatment of depression and other affective disorders
|
|
US20040185170A1
(en)
|
2003-03-21 |
2004-09-23 |
Shubha Chungi |
Method for coating drug-containing particles and formulations and dosage units formed therefrom
|
|
US20080206138A1
(en)
|
2003-08-06 |
2008-08-28 |
Ilse Zolle |
Radiolabelled Phenylethyl Imidazole Carboxylic Acid Ester Derivatives
|
|
BRPI0414238A
(pt)
|
2003-09-09 |
2006-10-31 |
Ono Pharmaceutical Co |
antagonistas de crf e compostos heterobicìclicos
|
|
US20050203130A1
(en)
|
2003-12-02 |
2005-09-15 |
Erik Buntinx |
Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
|
|
JPWO2005061508A1
(ja)
|
2003-12-22 |
2007-07-12 |
小野薬品工業株式会社 |
三環式複素環化合物およびその化合物を有効成分とする医薬
|
|
JP4399593B2
(ja)
|
2004-04-01 |
2010-01-20 |
国立大学法人 千葉大学 |
インフルエンザ脳症の検査法、及び、ヒト髄液中に発現するタンパク質からなるマーカ、診断薬、診断キット
|
|
CA2568159A1
(en)
|
2004-05-28 |
2005-12-15 |
Speedel Experimenta Ag |
Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
|
|
JP2008500998A
(ja)
|
2004-05-28 |
2008-01-17 |
シュペーデル・エクスペリメンタ・アーゲー |
複素環式化合物およびアルドステロンシンターゼ阻害薬としてのそれらの使用
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
US9415107B2
(en)
|
2005-11-10 |
2016-08-16 |
Board Of Supervisors Of Louisiana State University & Agricultural & Mechanical College |
Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
|
|
CA2643802A1
(en)
|
2006-02-27 |
2007-09-07 |
Alexander Michalow |
Methods for regulating neurotransmitter systems by inducing counteradaptations
|
|
JP5197569B2
(ja)
|
2006-03-29 |
2013-05-15 |
ノバルティス アーゲー |
有機化合物
|
|
MX2009006631A
(es)
|
2006-12-18 |
2009-06-30 |
Novartis Ag |
Imidazoles como inhibidores de sintasa de aldosterona.
|
|
WO2008079868A1
(en)
|
2006-12-22 |
2008-07-03 |
Drugtech Corporation |
Clonidine composition and method of use
|
|
WO2009035473A2
(en)
|
2007-09-13 |
2009-03-19 |
Sanfilippo Louis C |
Method of treating binge eating disorder, obesity resulting from binge eating behavior and depressive disorders
|
|
US8475823B2
(en)
|
2008-04-18 |
2013-07-02 |
Medtronic, Inc. |
Baclofen formulation in a polyorthoester carrier
|
|
DE102008022221A1
(de)
|
2008-05-06 |
2009-11-12 |
Universität des Saarlandes |
Inhibitoren der humanen Aldosteronsynthase CYP11B2
|
|
AR072297A1
(es)
|
2008-06-27 |
2010-08-18 |
Novartis Ag |
Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
|
|
US8771735B2
(en)
|
2008-11-04 |
2014-07-08 |
Jazz Pharmaceuticals, Inc. |
Immediate release dosage forms of sodium oxybate
|
|
CA2761858A1
(en)
|
2009-05-15 |
2010-11-18 |
Novartis Ag |
5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
|
|
SG175925A1
(en)
|
2009-05-15 |
2011-12-29 |
Novartis Ag |
Aryl pyridine as aldosterone synthase inhibitors
|
|
AU2010247391A1
(en)
|
2009-05-15 |
2011-12-01 |
Novartis Ag |
Benzoxazolone derivatives as aldosterone synthase inhibitors
|
|
US8541404B2
(en)
|
2009-11-09 |
2013-09-24 |
Elexopharm Gmbh |
Inhibitors of the human aldosterone synthase CYP11B2
|
|
WO2011061168A1
(en)
|
2009-11-17 |
2011-05-26 |
Novartis Ag |
Aryl-pyridine derivatives as aldosterone synthase inhibitors
|
|
WO2011064769A1
(en)
|
2009-11-24 |
2011-06-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and pharmaceutical compositions for the treatment of hot flashes
|
|
US8575160B2
(en)
|
2009-11-30 |
2013-11-05 |
Novartis Ag |
Imidazole derivatives as aldosterone synthase inhibitors
|
|
HUE041967T2
(hu)
|
2010-01-14 |
2019-06-28 |
Novartis Ag |
Mellékvese hormon-módosító szer alkalmazása
|
|
KR20130135820A
(ko)
|
2010-06-16 |
2013-12-11 |
엠베라 뉴로 테라퓨틱스 인코포레이티드 |
중독，정신 장애 및 신경퇴행성 질환 치료용 조성물 및 방법
|
|
US20120237482A1
(en)
|
2011-03-18 |
2012-09-20 |
Juan Rodriguez |
Methods for treatment of neurological disorders by modulation of microglial activation
|
|
US20150278438A1
(en)
|
2012-04-23 |
2015-10-01 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Genetic predictors of response to treatment with crhr1 antagonists
|
|
WO2014131825A1
(en)
|
2013-03-01 |
2014-09-04 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations comprising quetiapine and escitalopram
|
|
EP3013342B1
(en)
|
2013-06-27 |
2021-04-14 |
Cedars-Sinai Medical Center |
Adrenoceptors antagonists for the prevention and treatment of neurodegenerative conditions
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
CN104288385A
(zh)
|
2014-10-23 |
2015-01-21 |
朱道明 |
一种戒毒中药
|
|
CA2990413A1
(en)
*
|
2015-06-22 |
2016-12-29 |
Embera Neurotherapeutics, Inc. |
Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders
|
|
US9598459B2
(en)
*
|
2015-08-03 |
2017-03-21 |
Pop Test Oncology Llc |
Pharmaceutical compositions and methods
|
|
US20200016134A1
(en)
|
2016-02-16 |
2020-01-16 |
Embera Neurotherapeutics, Inc. |
Compositions and methods for treating substance abuse disorders
|
|
US20190275058A1
(en)
|
2016-03-04 |
2019-09-12 |
Embera Neurotherapeutics, Inc. |
Compositions and methods for treating addiction or substance use disorders
|
|
US20200360400A1
(en)
|
2017-05-19 |
2020-11-19 |
Embera Neurotherapeutics, Inc. |
Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
|